Researchers at Boston Children's Hospital have found a new way to non-invasively relieve pain at local sites in the body; such systems could one day improve pain management by replacing addictive opioids and short-lasting ...
Aug 10, 2017
0
100
The type 2 diabetes drug tirzepatide (better known by its brand name Mounjaro) has recently been authorized by the UK's medicines regulation authority for use in weight loss and weight management. The decision was made on ...
Nov 15, 2023
0
0
Research at the University of Wisconsin–Madison's Center for Healthy Minds has isolated the changes in pain-related brain activity that follow mindfulness training—pointing a way toward more targeted and precise pain ...
Jul 28, 2022
0
144
Argenx, a Belgium pharmaceutical company, recently announced that The Lancet Neurology has published pivotal trial results from the Phase 3 ADAPT trial of efgartigimod, an FcRn antagonist, for the treatment of adults living ...
Jun 18, 2021
0
3
Investigators have discovered that a subset of sensory neurons promote osteoarthritis-related joint pain and inflammation, suggesting a new therapeutic target for pain management, according to findings published in Nature ...
Jun 12, 2023
0
104
Different groups of drugs are used for the treatment of rheumatic conditions. They are intended to suppress the rogue immune system which attacks its own body. It is unclear to date whether the use of immunosuppressants increases ...
Jun 3, 2020
0
1
Kentucky's 2007 lawsuit against Purdue Pharma marked a major turn in the opioid crisis. It was the first time a member of the Sackler family, who owned Purdue, was deposed about the company's role in the opioid epidemic. ...
Aug 3, 2023
0
21
Scott Gottlieb, commissioner of the Food and Drug Administration, told The Washington Post this week that his agency will require drug companies to study whether opioids that are already on the market actually work for chronic ...
Feb 27, 2019
1
12
Opioid pain-relieving medicines are not more effective than a placebo in relieving acute back and neck pain and may even cause harm, according to a world-first trial led by the University of Sydney.
Jun 28, 2023
0
239
Neurologists must make sure Alzheimer's patients and their families understand that the controversial drug aducanumab does not restore mental function, the American Academy of Neurology (AAN) said in new position statement ...
Nov 18, 2021
0
11
